Navigation Links
Kids Squeeze 'Aid' Out of Lemons as Take a Stand(R) Program Launches Nationwide
Date:5/13/2008

Sunkist Take a Stand Campaign Returns For Its Fifth Year to Give Away

20,000 Free Lemonade Stands to Kids Raising Money For Charity

SHERMAN OAKS, Calif., May 13 /PRNewswire/ -- The Sunkist Take a Stand(R) campaign is back for a fifth year and bigger than ever. This year Sunkist Growers, with proud supporters Rubbermaid(R) and Domino(R)/C&H(R) Sugar, continue to promote youth philanthropy with the distribution of 20,000 free lemonade stands to kids who pledge to raise money for a charity of their choice. The award-winning cause-marketing program encourages young people across the country to give back to their community by donating their earnings from a good old-fashioned lemonade sale.

Over the past four years Sunkist has shipped out more than 30,000 free lemonade stands to help kids with their charitable efforts. Since its inception, Take a Stand has raised an estimated $2.8 million for charity by kids in every state in the U.S. and every province in Canada, one glass of fresh-squeezed Sunkist lemonade at a time. To receive a complimentary stand, children must be 7-12 years of age and pledge their commitment to a charity online at: http://www.sunkist.com/takeastand.

According to research and nonprofit organizations such as the Council on Foundations, today's youth are more involved in philanthropy than ever before. As young kids increasingly become aware of social issues around the world through the Internet and television, programs like Sunkist Take a Stand offer a unique and fun way for parents to instill in their children the value of giving.

"Take a Stand provides children with a voice and role in the community," said Claire Smith, Director of Corporate Communications for Sunkist Growers. "It enables kids to take action on issues that are important to them, while building their leadership skills and nourishing community involvement so they become better citiz
'/>"/>

SOURCE Sunkist
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. IBM world community grid squeezes decades of cancer research into 2 years
2. BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11
3. Using coxibs and NSAIDs to treat osteoarthritis
4. Preclinical study suggests organ-transplant drug may aid in lupus fight
5. New Drug Aids Muscle Function in Myasthenia Gravis
6. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. USAID Provides Additional Wildfire Assistance to Greece
9. Link Uncovered Between Benign Prostatic Hyperplasia and NSAIDs, Says Harvard Mens Health Watch
10. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
11. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...tive against Lennox-Gastaut syndrome , ,...lled Banzel (rufinamide) has been approved as a su...y called Lennox-Gastaut syndrome, the U.S. Food an...pproval was based on results of a four-month clini...pared to patients who took a placebo, those who to...
(Date:11/21/2008)...swire-USNewswire/ -- New research at West Virgini...itless tobacco product aimed at young adults is ca...Reynolds, Camel Snus - touted as a socially accept...gly high levels of nicotine. , , "Camel Snu...ducts," said Bruce Adkins of the state Division of...
(Date:11/21/2008)...re-USNewswire/ -- U.S. News & World Report and...A) ranked BlueChoice(R) HealthPlan of South Caroli...(TM), published in U.S. News & World Report,s ...anking ranks the nation,s best health plans based ...accreditation scores. NCQA and U.S. News & Wor...
(Date:11/21/2008)...re-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE:...rwhelmingly approved the proposals submitted to th...rmaceuticals Industries Ltd. (Nasdaq: TEVA ). ,...ing support of the transaction by the Barr shareho...CEO. "We are pleased with the progress that we con...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...or high-risk medication by the FDA, doctors have b...y care patients. The percentage of patients found ... to a survey conducted by Harvard Medical School a...onse of the doctors to comply with recommendations...
...rve transplant on Thursday, hoping to restore the ...gery on Nick Anderson of Atco, N.J., went as plann...uccess in a few months, said Eric Vohr, a spokesma...ave an inkling of potential success in three month...
...golden statement that has withstood the test of ti...bal survey revealing that nearly one-third of all ... are properly taken care of. The study was part of.... Amongst, the modifiable risk factors, tobacco le...
...ot alone. Statistics Canada says more than three m...y get 6-1/2 hours of sleep a night compared with 7...18 per cent of the insomniacs averaged less than f...re's a substantial number of Canadians -- 13 per c...
Other Medicine News:Health News:Doctors Do Not Excise Sufficient Caution While Prescribing High-Risk Drugs 2Health News:Doctors Finish Mother-To-Son Nerve Surgery 2Health News:One Third Of All Cancers Preventable! 2
(Date:11/20/2008)...Nov. 20 New Jersey American Water ... for its customers in the following municipalities..., Middlesex County , , , Dunelle...ataway , South Plainfield , , , ...rook , Bridgewater , Green Brook , ...
(Date:11/20/2008)... Nov. 20 Bionovo, Inc.,...nt results from the Phase 1B,clinical trial of th...east,cancer, BZL101, at the Society for Integrati...tlanta, Georgia. The Company,s oral presentation ...e presented as a part of the Best of the,SIO Sess...
(Date:11/20/2008)... November 20 The Scandinavian-base...nounced results of studies on its,lead antimicrob...ngton, DC,the studies showed that the novel lyti... effect, significantly better towards killing Stap... marketed gold standard drugs. In,addition to thi...
(Date:11/19/2008)... Nov. 19 Biotech scientists increa...ology research to better understand the effects of...ms, reports Genetic Engineering & Biotechnolo...n figuring out a new compound,s mechanism of actio...y technique, according to the November 15 issue of...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Take Care Health Systems Names Butler Shine Stern 26 Partners as First Marketing Agency of Record 14322 1Take Care Health Systems Names Butler Shine Stern 26 Partners as First Marketing Agency of Record 14322 2Take Care Health Systems Names Butler Shine Stern 26 Partners as First Marketing Agency of Record 14322 3New research provides dynamic visualization of simplest circadian clock 14321 1New research provides dynamic visualization of simplest circadian clock 14321 2All eyes and ears on the corn genome 2496 1All eyes and ears on the corn genome 2496 2All eyes and ears on the corn genome 2496 3Study in Circulation Research details how diabetes drives atherosclerosis 14319 1Study in Circulation Research details how diabetes drives atherosclerosis 14319 2Study in Circulation Research details how diabetes drives atherosclerosis 14319 3
... 15 /CNW/ - Today AMADEO, one of the,first studies...tensin receptor blockers in hypertensive patients...uropean Society,of Hypertension, Milan. The resul...proteinuria to a significantly greater extent,than... Prof. Ellen Burgess, Foothills Hospital,in Calga...
... 2007 /PRNewswire-FirstCall/ -- Anadys,Pharmaceuti... to,the discovery, development and commercializati...is and cancer, announced today that it,has nominat...as an,orally-administered direct antiviral for the...ction. , "We have identified a small-molecule, non...
Other Medicine Technology:New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 2Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 3Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 4
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: